We serve Chemical Name:2,4-dichloro-6-methylbenzenesulfonamide CAS:568577-80-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,4-dichloro-6-methylbenzenesulfonamide
CAS.NO:568577-80-0
Synonyms:2,4-Dichloro-6-methylbenzenesulphonamide;2,4,5-TRIFLUORO-D-PHENYLALANINE
Molecular Formula:C7H7Cl2NO2S
Molecular Weight:240.10700
HS Code:2924299090
Physical and Chemical Properties:
Melting point:168ºC
Boiling point:395ºC at 760 mmHg
Density:1.514g/cm3
Index of Refraction:1.589
PSA:68.54000
Exact Mass:238.95700
LogP:3.73030
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2,4-Dichloro-6-methylbenzenesulphonamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4,5-TRIFLUORO-D-PHENYLALANINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4,5-TRIFLUORO-D-PHENYLALANINE Use and application,2,4-Dichloro-6-methylbenzenesulphonamide technical grade,usp/ep/jp grade.
Related News: Specifically, the EC has cleared Verquvo (vericiguat) to treat patients who are stabilised after a recent decompensation event requiring intravenous therapy. 6-Methoxy-7-(2-methoxyethoxy)-4-oxo-1,4-dihydro-3-quinolinecarbon itrile manufacturers Specifically, the EC has cleared Verquvo (vericiguat) to treat patients who are stabilised after a recent decompensation event requiring intravenous therapy. tubocurarine suppliers Over the duration of this study, investigators observed a 4.2% reduction in annualised absolute risk of cardiovascular death or heart failure hospitalisations compared to placebo. 5,6-diphenyl-2,3-dihydro-1,4-oxathiine vendor & factory Jan Vertommen, Senior Director, Commercial Development, Lonza, said, “Increasing our capabilities by adding mid-scale API manufacturing at our site in Nansha will benefit our customers, and especially the many global emerging biotech companies we partner with.,“Partnering with a CDMO that has the skills and capabilities to execute a successful tech transfer is critical, as this complex, multi-step process helps lay the foundation for the new drug’s journey through to commercialization.
